Innovative Oncology Solutions Cannabotech is actively developing targeted cancer therapies, including formulas for pancreatic, colorectal, breast, lung, and prostate cancers, which presents an opportunity to collaborate with healthcare providers seeking advanced botanical-based oncology treatments.

Digital Engagement Platform The launch of the My Being App demonstrates a focus on digital health monitoring and personalized patient engagement, opening avenues for sales of telemedicine integrations, health tracking tools, and remote patient support services.

Partnership Expansion Recent collaborations with NXTLVL for oncology product manufacturing in California highlight potential for expanding distribution channels and establishing strategic partnerships in both medical device and pharmaceutical markets.

Personalized Medicine Development Cannabotech’s work on developing personalization systems and diagnostic tools indicates opportunities to sell customized treatment solutions and diagnostics to medical practitioners and clinics focusing on precision medicine.

Growth and Investment Potential With a revenue range of 1M to 10M and recent assets acquisitions, Cannabotech is positioned for growth, making it an attractive prospect for investors and business partners looking to enter or expand within the botanical and medical cannabis sectors.